139 related articles for article (PubMed ID: 34223992)
21. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
[TBL] [Abstract][Full Text] [Related]
22. RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase transition process.
Ke Y; Guo W; Huang S; Li Y; Guo Y; Liu X; Jin Y; Ma H
Life Sci; 2020 Jun; 250():117578. PubMed ID: 32209426
[TBL] [Abstract][Full Text] [Related]
23. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
[TBL] [Abstract][Full Text] [Related]
24. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma.
Macedo-Silva C; Miranda-Gonçalves V; Lameirinhas A; Lencart J; Pereira A; Lobo J; Guimarães R; Martins AT; Henrique R; Bravo I; Jerónimo C
Cell Death Dis; 2020 Dec; 11(12):1068. PubMed ID: 33318475
[TBL] [Abstract][Full Text] [Related]
25. [The association between the whole blood riboflavin level and the occurrence, development and prognosis of esophageal squamous cell carcinoma].
Li SS; Tan HZ; Xu YW; Wu ZY; Wu JY; Zhao XK; Wang LD; Long L; Li EM; Xu LY; Zhang JJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1124-1129. PubMed ID: 31683399
[No Abstract] [Full Text] [Related]
26. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
[TBL] [Abstract][Full Text] [Related]
27. FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features.
Islam F; Gopalan V; Law S; Tang JC; Lam AK
Hum Pathol; 2019 May; 87():1-10. PubMed ID: 30794892
[TBL] [Abstract][Full Text] [Related]
28. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
29. Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.
Yang Z; Ni W; Cui C; Qi W; Piao L; Xuan Y
Hum Pathol; 2018 Nov; 81():148-156. PubMed ID: 30031102
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
Li N; Yu Y; Wang B
Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
[TBL] [Abstract][Full Text] [Related]
31. The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.
Zeng B; Zhang X; Zhao J; Wei Z; Zhu H; Fu M; Zou D; Feng Y; Luo H; Lei Y
BMC Cancer; 2019 Jun; 19(1):609. PubMed ID: 31226958
[TBL] [Abstract][Full Text] [Related]
32. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.
Chen Q; Hou J; Wu Z; Zhao J; Ma D
Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625
[TBL] [Abstract][Full Text] [Related]
33. A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression.
Dong D; Zhang W; Xiao W; Wu Q; Cao Y; Gao X; Huang L; Wang Y; Chen J; Wang W; Zhan Q
Cancer Res; 2021 Feb; 81(4):910-922. PubMed ID: 33323378
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-429 inhibits the proliferation and migration of esophageal squamous cell carcinoma cells by targeting RAB23 through the NF-κB pathway.
Wang Y; Yu XJ; Zhou W; Chu YX
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1202-1210. PubMed ID: 32096149
[TBL] [Abstract][Full Text] [Related]
35. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
36. TIM-3 polymorphism is involved in the progression of esophageal squamous cell carcinoma by regulating gene expression.
Cui SJ; Li Y; Zhou RM; Liu L; Cao SR; Huang X; Huo XR; Wang N
Environ Mol Mutagen; 2021 Apr; 62(4):273-283. PubMed ID: 33723872
[TBL] [Abstract][Full Text] [Related]
37. Widely targeted metabolomic analyses unveil the metabolic variations after stable knock-down of NME4 in esophageal squamous cell carcinoma cells.
Zheng S; Liu T; Liu Q; Yang L; Zhang Q; Han X; Shen T; Zhang X; Lu X
Mol Cell Biochem; 2020 Aug; 471(1-2):81-89. PubMed ID: 32504364
[TBL] [Abstract][Full Text] [Related]
38. GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.
Li T; Xu L; Teng J; Ma Y; Liu W; Wang Y; Chi X; Shao S; Dong Y; Zhan Q; Liu X
Dig Dis Sci; 2020 Apr; 65(4):1032-1041. PubMed ID: 31562612
[TBL] [Abstract][Full Text] [Related]
39. PARP1 Gene Polymorphisms and the Prognosis of Esophageal Cancer Patients from Cixian High-Incidence Region in Northern China.
Zhou RM; Li Y; Wang N; Niu CX; Huang X; Cao SR; Huo XR
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2987-2992. PubMed ID: 33112558
[TBL] [Abstract][Full Text] [Related]
40. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
